Candel Therapeutics, Inc.CADLNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank83
3Y CAGR-14.1%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-14.1%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $10.08M | +146.2% |
| 2024 | $-21.81M | -4924.3% |
| 2023 | $452000.00 | -97.2% |
| 2022 | $15.93M | +253.2% |
| 2021 | $-10.40M | -168.7% |
| 2020 | $-3.87M | -585.6% |
| 2019 | $797000.00 | - |